Nanohale AG (ETR:FYB) | Finanzwire

Basculer en Français

10058	Companies
205602	Keywords
135838	Articles
109006	Press releases

Home
Companies
Nanohale AG

BRIEF

published on 03/19/2026 at 06:35, 2 days 17 hours ago

Formycon Secures Licensing for Biosimilar in Europe and Beyond

Market Expansion Formycon Retinal Diseases Biosimilar Licensing Patent Settlement
PRESS RELEASE

published on 03/19/2026 at 06:30, 2 days 17 hours ago

Formycon secures license date for aflibercept 2 mg biosimilar FYB203 in Europe and further territories following settlement with Regeneron and Bayer
Formycon secures license date for aflibercept 2 mg biosimilar FYB203 in Europe and further territories following settlement with Regeneron and Bayer

Bayer Biosimilar Formycon Regeneron Aflibercept
BRIEF

published on 03/18/2026 at 18:58, 3 days 4 hours ago

Formycon AG Delays 2025 Financial Statement Publication

Regulatory Compliance Financial Statement Formycon AG Postponement 2025 Results
PRESS RELEASE

published on 03/18/2026 at 18:53, 3 days 4 hours ago

EQS-Adhoc: Formycon AG postpones the publication of its audited annual and consolidated financial statements for 2025
Formycon AG postpones the publication of its audited annual and consolidated financial statements for 2025 due to internal system changes, extended reconciliation work, and audit delays

Formycon AG Postponement 2025 Audited Financial Statements Internal System Changes
BRIEF

published on 03/04/2026 at 22:55, 17 days ago

Formycon AG Reports Preliminary 2025 Fiscal Year Figures

Working Capital EBITDA Forecast Formycon AG Revenue Shortfall 2025 Financial Results
PRESS RELEASE

published on 03/04/2026 at 22:50, 17 days ago

EQS-Adhoc: Formycon AG publishes preliminary figures for the 2025 fiscal year
Formycon AG publishes preliminary figures for the 2025 fiscal year including revenue and EBITDA updates, expects improvements in adjusted EBITDA and working capital

EBITDA Revenue Formycon AG Preliminary Figures 2025 Fiscal Year
BRIEF

published on 02/25/2026 at 06:35, 24 days 17 hours ago

Formycon Reports Positive Clinical Data for Keytruda® Biosimilar FYB206

Formycon AG Clinical Data Pharmacokinetic Study FYB206 Keytruda® Biosimilar
PRESS RELEASE

published on 02/25/2026 at 06:30, 24 days 17 hours ago

Formycon announces positive clinical data for Keytruda® biosimilar candidate FYB206 (pembrolizumab)
Formycon announces positive clinical data for Keytruda biosimilar candidate FYB206 (pembrolizumab), confirming pharmacokinetic equivalence with Keytruda

Clinical Data Biosimilar Formycon Keytruda Pembrolizumab
BRIEF

published on 02/11/2026 at 06:40, 1 month 10 days ago

Lotus Pharmaceutical to Commercialize Formycon's Keytruda® Biosimilar in Asia-Pacific

Asia-Pacific Market Formycon Lotus Pharmaceutical Keytruda® Biosimilar Oncology Treatment
PRESS RELEASE

published on 02/11/2026 at 06:35, 1 month 10 days ago

Lotus Pharmaceutical becomes commercialization partner for Formycon's Keytruda® biosimilar candidate FYB206 across major parts of the Asia-Pacific Region
Lotus Pharmaceutical partners with Formycon AG for commercialization of Keytruda biosimilar FYB206 in Asia-Pacific region, marking a key step in Formycon's global strategy

Formycon AG Keytruda Biosimilar Oncology Therapy Lotus Pharmaceutical Asia-Pacific Region

Accesswire

Published on 03/20/2026 at 23:00, 1 day ago

Cypher Announces Private Placement
Published on 03/20/2026 at 21:30, 1 day 2 hours ago

Sky Gold Sets Options
Published on 03/20/2026 at 21:15, 1 day 2 hours ago

Earthwise Minerals Announces Private Placement
Published on 03/20/2026 at 13:30, 1 day 10 hours ago

Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 1 day 11 hours ago

CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals

View all ACCESSWIRE

EQS Group

Published on 03/20/2026 at 22:45, 1 day ago

Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 1 day 2 hours ago

Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 1 day 2 hours ago

Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 21:00, 1 day 2 hours ago

BRP Unveils the Winners of its 6th International Design Challenge
Published on 03/20/2026 at 20:05, 1 day 3 hours ago

INVESTOR ALERT: Goeasy Ltd. Shareholder Class Action

Les Echos

Published on 03/20/2026 at 19:00, 1 day 4 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 18:15, 1 day 5 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 17:45, 1 day 5 hours ago

Cie du Bois Sauvage : Annual report 2025
Published on 03/20/2026 at 16:57, 1 day 6 hours ago

Number of shares and voting rights - February 2026 (In French only)
Published on 03/19/2026 at 18:00, 2 days 5 hours ago

Filing of the 2025 Universal Registration Document

View all LES ECHOS COMFI WIRE